HOME > Projects > Novel Integrated Area Unit


Novel Integrated Area Unit



Development of home medical device for repetitive transcranial magnetic stimulation for the treatment of post-stroke, intractable neuropathic pain

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive treatment for intractable pain etc. However, no rTMS devices have been approved and clinical studies use foreign rTMS devices in Japan. There is a rumor that rTMS devices made in USA for the depression treatment will be approved in Japan soon. As a session of rTMS treatment temporarily alleviates pain, a device that can be used at home repeatedly is desired. Research is collaborated with doctors of engineering of the University of Tokyo, Osaka University and Kansai University, and research workers of Teijin Pharma to develop a home-use rTMS device. As our device has been developed, an investigator-initiated trial has begun. Once the trial concludes, the application for approval will be submitted and we will expand the treatment indications in other nervous diseases. We also have plans to develop the next generation of rTMS devices.

Responsible Department

Department of Neuromodulation and Neurosurgery

Research Partner

Teijin Pharma Limited

Project Members

Principal Investigator

SAITOH Youichi

Specially Apointed Professor

Department of Neuromodulation and Neurosurgery